Data / Form D filings / Emergent BioSolutions Inc.
Emergent BioSolutions Inc.: Form D filing
Emergent BioSolutions Inc., a biotechnology company in Gaithersburg, MD, filed a Form D with the SEC in 2018. The latest, on October 30, 2018, reports $47.9 million sold of a $47.9 million offering to 8 investors.
Find out what Emergent BioSolutions Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 400 PROFESSIONAL DR, SUITE 400, Gaithersburg, MD, 20879
- Phone
- (240) 631-3200
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1367644
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 30, 2018 | New notice | $47,870,412 | $47,870,412 | $0 | 8 | Oct 15, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| George J. Joulwan | Director | |
| Robert G Kramer | Executive Officer | |
| Ronald B Richard | Director | |
| Katherine R Strei | Executive Officer | |
| Fuad El-Hibri | Director, Executive Officer | |
| Adam R Havey | Executive Officer | |
| Sue J Bailey | Director | |
| Daniel J Abdun-Nabi | Executive Officer, Director | |
| Louis W Sullivan | Director | |
| Zsolt J. Harsanyi | Director | |
| Kathryn C Zoon | Director | |
| Jerome M Hauer | Director | |
| Richard S. Lindahl | Executive Officer | |
| Atul R Saran | Executive Officer |
Other biotechnology companies in Maryland that filed recently
- BlueHealer Inc. $1 · Nov 4, 2026
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
- Gliknik Inc $15 million · Sep 17, 2026
- Georgiamune, Inc. $92.7 million · Aug 17, 2026
Every Form D from the week of Oct 29, 2018 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Emergent BioSolutions Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.